Purified influenza A virus N2 neuraminidase vaccine is immunogenic and non-toxic in humans

By Kilbourne E.D.   Couch R.B.   Kasel J.A.   Keitel W.A.   Cate T.R.   Quarles J.H.   Grajower B.   Pokorny B.A.   Johansson B.E.  

Vaccine, Vol. 13, Iss. 18, 1995-01 ,pp. : 1799-1803

Elsevier

Access to resources Recommend Favorite

Cross-protection against a lethal influenza virus infection by DNA vaccine to neuraminidase

By Chen Z.   Kadowaki S.-E.   Hagiwara Y.   Yoshikawa T.   Matsuo K.   Kurata T.   Tamura S.-I.  

Vaccine, Vol. 18, Iss. 28, 2000-08 ,pp. : 3214-3222

Elsevier

Access to resources Recommend Favorite

Supplementation of conventional influenza A vaccine with purified viral neuraminidase results in a balanced and broadened immune response

By Johansson B.E.   Matthews J.T.   Kilbourne E.D.  

Vaccine, Vol. 16, Iss. 9, 1998-05 ,pp. : 1009-1015

Elsevier

Access to resources Recommend Favorite

Immunization with influenza A virus hemagglutinin and neuraminidase produced in recombinant baculovirus results in a balanced and broadened immune response superior to conventional vaccine

By Johansson B.E.  

Vaccine, Vol. 17, Iss. 15, 1999-04 ,pp. : 2073-2080

Elsevier

Access to resources Recommend Favorite

Recombinant neuraminidase vaccine protects against lethal influenza

By Deroo T.   Willy M.J.   Fiers W.  

Vaccine, Vol. 14, Iss. 6, 1996-04 ,pp. : 561-569

Elsevier

Access to resources Recommend Favorite